HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endocyclophotocoagulation as an adjuvant to vitreoretinal surgery in cases with concomitant glaucoma.

AbstractBACKGROUND AND OBJECTIVE:
To evaluate the efficacy of endocyclophotocoagulation (ECP) in patients undergoing pars plana vitrectomy for vitreoretinal disease with medically uncontrolled glaucoma.
PATIENTS AND METHODS:
This is a retrospective review of 12 patients who underwent 270° ECP following vitrectomy.
RESULTS:
Ten of the 12 patients had excellent intraocular pressure (IOP) control postoperatively, without medication in four patients and with reduced medication in six patients. IOP decreased from 26.3 ± 12.9 to 17.9 ± 6.0 at 1 month (P = .03) and 16.9 ± 4.4 at 3 months postoperatively (P = .02). Best corrected visual acuity was improved by 1 month postoperatively. The number of glaucoma agents decreased from 2.7 ± 1.1 to 1.3 ± 1.3 (P = .03). One patient with neovascular glaucoma developed hypotony. Postoperative inflammation or discomfort did not exceed what was expected for a standard vitrectomy in any patient.
CONCLUSION:
ECP can be effectively combined with vitrectomy; however, ECP produced unpredictable results in the two patients with neovascular glaucoma.
AuthorsIan R Gorovoy, Andrew W Eller
JournalOphthalmic surgery, lasers & imaging retina (Ophthalmic Surg Lasers Imaging Retina) 2013 May-Jun Vol. 44 Issue 3 Pg. 243-7 ISSN: 2325-8179 [Electronic] United States
PMID23676225 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2013, SLACK Incorporated.
Chemical References
  • Antihypertensive Agents
Topics
  • Antihypertensive Agents (therapeutic use)
  • Combined Modality Therapy
  • Glaucoma (physiopathology, surgery)
  • Humans
  • Intraocular Pressure (physiology)
  • Light Coagulation (adverse effects, methods)
  • Retrospective Studies
  • Uvea (surgery)
  • Visual Acuity (physiology)
  • Vitrectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: